SULVERAPRIDE

Details

Stereochemistry	RACEMIC
Molecular Formula	C16H25N3O5S
Molecular Weight	371.452
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CNS(=O)(=O)C1=CC(C(=O)NCC2CCCN2C)=C(OC)C(OC)=C1

InChI

InChIKey=SODOSTUXGWHQII-UHFFFAOYSA-N

InChI=1S/C16H25N3O5S/c1-17-25(21,22)12-8-13(15(24-4)14(9-12)23-3)16(20)18-10-11-6-5-7-19(11)2/h8-9,11,17H,5-7,10H2,1-4H3,(H,18,20)

HIDE SMILES / InChI

Molecular Formula	C16H25N3O5S
Molecular Weight	371.452
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description
Sources: https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19800430&CC=DE&NR=2939914A1&KC=A1 | https://www.ncbi.nlm.nih.gov/pubmed/6518973

Sulverapride is a methylsulfamoylbenzamide derivative patented by Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France for the treatment of lower urinary tract disorders

Originator

Approval Year

PubMed

Title	Date	PubMed
In vitro transfer of six benzamides in the human placenta.	1984	6518973

Patents

Substance Class	Chemical Created by `admin` on `Wed Apr 02 08:44:20 GMT 2025` Edited by `admin` on `Wed Apr 02 08:44:20 GMT 2025`
Record UNII	87C4V63NWI
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SULVERAPRIDE

Official Name

English

sulverapride [INN]

Preferred Name

English

Classification Tree Code System Code

NCI_THESAURUS

C66883